FDA Making COVID Vax Decision Based on a Study of 10
The FDA announced they were reviewing data for a COVID vaccine for children ages 6 months to under 5 years. But the data are based on just 10 children.
STORY AT-A-GLANCE
Pfizer announced preliminary data from Phase 2/3 trials in children 6 months to under 5 years would be submitted to the FDA for emergency use authorization; the data are based on 1,678 children and 10 who got sick, which Pfizer claims is an 80.3% effectiveness rate
Even vaccine advocate Dr. Paul Offit is dismayed at the number from which…
Keep reading with a 7-day free trial
Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.